This examination of the economics of the biopharmaceutical industry has 18 chapters by health economists. Part 1 examines the economics of biopharmaceutical innovation. Part 2 examines the market for biopharmaceuticals with chapters on prices and reimbursement in industrialised and developing...

This article reports empirical evidence concerning the effects of solvency regulation on the number of companies and frequency of insolvencies. Minimum capital requirements appear to reduce insolvencies by reducing the number of small, domestic firms. This supports the view of capital...